| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.1999.1796 |
| P698 | PubMed publication ID | 10581185 |
| P2093 | author name string | Q Zhang | |
| Q Liu | |||
| C T Caskey | |||
| S R George | |||
| R Wang | |||
| Z Zeng | |||
| C P Austin | |||
| D L Williams | |||
| C Bai | |||
| J F Evans | |||
| T P McDonald | |||
| M Davidoff | |||
| S S Pong | |||
| A D Howard | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 174-8 | |
| P577 | publication date | 1999-12-09 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 | |
| P478 | volume | 266 |
| Q36492706 | A closer look at the role of urotensin II in the metabolic syndrome |
| Q89884928 | Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study |
| Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
| Q28260943 | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes |
| Q35043105 | Cardiostimulant effects of urotensin-II in human heart in vitro |
| Q54708765 | Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. |
| Q34204062 | Characterization of the true ortholog of the urotensin II-related peptide (URP) gene in teleosts |
| Q35191049 | Comparative distribution and in vitro activities of the urotensin II-related peptides URP1 and URP2 in zebrafish: evidence for their colocalization in spinal cerebrospinal fluid-contacting neurons |
| Q34479147 | Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families |
| Q42215972 | Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice |
| Q43264253 | Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats |
| Q58855829 | Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin-II Lactam Analogues |
| Q42059806 | Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey |
| Q28188986 | Discovery and mapping of ten novel G protein-coupled receptor genes |
| Q34677468 | Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. |
| Q34260110 | Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity |
| Q73307200 | Effect of human urotensin-II infusion on hemodynamics and cardiac function |
| Q39018162 | Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell line |
| Q93551696 | G Protein-Coupled Receptors |
| Q43229377 | Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery. |
| Q28140469 | Human urotensin II mediates vasoconstriction via an increase in inositol phosphates |
| Q43927991 | Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists |
| Q47855077 | Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats |
| Q34204725 | Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease |
| Q24629423 | Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R |
| Q28577654 | Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception |
| Q35047377 | Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines |
| Q98629482 | Identification and signaling characterization of four urotensin II receptor subtypes in the western clawed frog, Xenopus tropicalis |
| Q28199576 | Identification of four novel human G protein-coupled receptors expressed in the brain |
| Q22254611 | Identification of receptors for neuromedin U and its role in feeding |
| Q28208515 | Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain |
| Q34546327 | Impact of gene/genome duplications on the evolution of the urotensin II and somatostatin families. |
| Q24672927 | Is urotensin-II the new endothelin? |
| Q48675996 | Localization of the urotensin II receptor in the rat central nervous system |
| Q40735770 | Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey |
| Q28574132 | Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium |
| Q34837608 | Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets |
| Q28202637 | Novel human G-protein-coupled receptors |
| Q34442018 | Orphan G protein-coupled receptors in the CNS. |
| Q34175467 | Orphan G-protein-coupled receptors and natural ligand discovery |
| Q24674639 | Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 |
| Q35128456 | Potential Clinical Implications of the Urotensin II Receptor Antagonists |
| Q34001118 | Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis |
| Q39084425 | RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells. |
| Q28182651 | Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects |
| Q37737495 | Role of urotensin II in health and disease |
| Q30658328 | Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research |
| Q58448612 | Somatostatin receptors |
| Q34278176 | Somatostatins and their receptors in fish |
| Q38533390 | State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
| Q28241656 | The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma |
| Q35100902 | The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems |
| Q34066190 | The relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer |
| Q24675590 | The role of urotensin II in cardiovascular and renal physiology and diseases |
| Q28211211 | The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat |
| Q42213734 | The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals |
| Q43146165 | The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation |
| Q38196857 | Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy |
| Q36760529 | Therapeutic potential of blockade of the urotensin II system in systemic hypertension |
| Q37082781 | Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? |
| Q51970096 | Transcriptional profiling of the megabladder mouse: a unique model of bladder dysmorphogenesis. |
| Q73746130 | UROTENSIN II: BETTER THAN SOMATOSTATIN FOR PORTAL HYPERTENSION? |
| Q41767436 | Update on the urotensinergic system: new trends in receptor localization, activation, and drug design |
| Q41819007 | Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta |
| Q28576132 | Urotensin II and renal function in the rat |
| Q44654245 | Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a “vasoconstrictor” with a unique hemodynamic profile |
| Q33378279 | Urotensin II in chronic liver disease: in vivo effect on vascular tone |
| Q36384743 | Urotensin II in invertebrates: from structure to function in Aplysia californica |
| Q48627768 | Urotensin II inhibits carotid sinus baroreflex in anesthetized male rats |
| Q44463826 | Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney |
| Q58949856 | Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease |
| Q43268409 | Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats |
| Q28584202 | Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons |
| Q50796108 | Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. |
| Q42876530 | Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats. |
| Q40470611 | Urotensin II stimulates plasma extravasation in mice via UT receptor activation. |
| Q48877778 | Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. |
| Q78700092 | Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling |
| Q74531840 | Urotensin II: a new mediator in cardiopulmonary regulation? |
| Q40166897 | Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension |
| Q28250440 | Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation |
| Q33846563 | Urotensin II: fish neuropeptide catches orphan receptor |
| Q37148984 | Urotensin II: lessons from comparative studies for general endocrinology. |
| Q93498779 | Urotensin-II |
| Q35779239 | Urotensin-II and the cardiovascular system--the importance of developing modulators |
| Q64940598 | Urotensin-II gene rs228648 polymorphism associated with the risk of diabetes mellitus. |
| Q42418210 | Urotensin-II: More Than a Mediator for Kidney |
| Q35536658 | Vasoconstrictive effects of endothelin-1, endothelin-3, and urotensin II in isolated perfused human lungs and isolated human pulmonary arteries |
| Q74162696 | Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries |
Search more.